Home/Filings/4/0001867872-26-000002
4//SEC Filing

Aranda Richard 4

Accession 0001867872-26-000002

CIK 0001728117other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:38 PM ET

Size

7.8 KB

Accession

0001867872-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
Aranda Richard
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2026-01-02+93,750463,106 total
  • Award

    Stock Option (Right to Buy)

    2026-01-02+562,500562,500 total
    Exercise: $2.88Exp: 2036-01-01Common Stock (562,500 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    2,539
Footnotes (2)
  • [F1]Represents restricted stock unit award, which will vest in four equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date.
  • [F2]25% of the total number of shares subject to the option will vest on January 2, 2027 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

Issuer

Gossamer Bio, Inc.

CIK 0001728117

Entity typeother

Related Parties

1
  • filerCIK 0001867872

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:38 PM ET
Size
7.8 KB